NAVNEET BOPARAI: Open Payments
NPI 1972210284 · ELK GROVE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$964 in 9 payments from 5 companies in 2025. Trend: 2023 $172 · 2024 $804 · 2025 $964
Food & beverage: $964
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 3 | $345 |
| E.R. Squibb & Sons, L.L.C. | 2 | $243 |
| Janssen Pharmaceuticals, Inc | 2 | $148 |
| Vanda Pharmaceuticals Inc. | 1 | $119 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $108 |
Products named: COBENFY, INGREZZA, SPRAVATO, FANAPT, REXULTI.
Industry payments across CA — which companies pay providers there.
